Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Mogadon 5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablets. Round, white tablets with " imprinted on one face with a single break bar on the other. The tablet can be divided into equal doses. |
Each tablet contains 5 mg of nitrazepam.
There is 301 mg lactose per tablet.
For the full list of excipients, See section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Nitrazepam |
Nitrazepam is a benzodiazepine compound with sedative properties. It acts in 30 to 60 minutes to produce sleep lasting 6 to 8 hours. |
| List of Excipients |
|---|
|
Each 5 mg tablet contains the following excipients: Lactose |
HDPE or glass bottles, in packs of 30 or 100.
PVC/Aluminium blister packs, containing 30 or 50 tablets.
Clic-loc containers, in a pack of 10.
Polypropylene mini-kegs, containing 5000 tablets.
Not all pack sizes may be marketed.
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 46302/0135
3 May 1999
| Drug | Countries | |
|---|---|---|
| MOGADON | Austria, Australia, Canada, France, Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
"